Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy or sell: Top stock trading ideas by market experts which are good short-term bets

      Rajesh Agarwal of AUM Capital recommends buying Sun Pharmaceutical Industries with stop loss at Rs 412 and target of Rs 431 and Bharat Petroleum Corporation with stop loss at Rs 320 and target of Rs 332.

    • Buy or sell: Top stock trading ideas by market experts which are good short-term bets

      Rajesh Agarwal of AUM Capital recommends buying Monte Carlo Fashions with stop loss at Rs 380 and target of Rs 400, Escorts with stop loss at Rs 694 and target of Rs 720 and Strides Pharma Science with stop loss at Rs 469 and target of Rs 505.

    • These 3 Indian pharma firms to benefit from warning letter to Mylan's US facility

      The slowdown in production at Morgantown site could provide a window of opportunity to Mylan's peers

    • These 10 stocks moved between 10-35%: Do you own any?

      Volatility index (India VIX) was up 3.2 percent this week. The BSE largecap index rose 0.69 percent, midcap gained 0.36 percent, while smallcap was down 1.27 percent

    • ICICI Direct sees Nifty heading to 10,760; bets on these 2 largecaps

      Dharmesh Shah of ICICIdirect.com does not expect the Nifty to breach its immediate support of 10,200

    • ICICI Bank, Exide among 10 picks which could give 20-30% returns by Diwali 2019

      HDFC Securities has selected the stock on two criteria – capital preservation (for now) and alpha generation (for later).

    • Selling pressure on higher levels likely; 4 stocks which could give double-digit returns

      Manali Bhatia of Rudra Shares and Stock Brokers said high volatility and sharp moves are expected this week as in the past years also, last week of October witnessed major falls and turn around, including in the year 2008.

    • 'Nifty could trade in 10,130-10,600 range this week, suggest staying away from HFCs, IT'

      "We couldn't see major downfall due to improvement in trade deficit & rupee appreciation. However volatility may persist in the market," Manali Bhatia of Rudra Shares & Stock Brokers said.

    • Top 10 short-term money making ideas that can give 3-17% return

      Going ahead, expect the index to undergo some time-correction for a while, but the range would be slightly wider. It's advisable to keep booking existing shorts and ideally adopt a stock-centric approach.

    • Buy Sun Pharmaceutical Industries, target Rs 647: Mazhar Mohammad

      Traders are advised to buy into this counter for a target of Rs 647 and a stop below Rs 589 on a closing basis, says Mazhar Mohammad of Chartviewindia.in.

    • Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

      Ashwani Gujral of ashwanigujral.com advises buying Adani Enterprises with a stoploss of Rs 148 and target of Rs 160.

    • Top 20 stocks to buy ahead of earnings season

      IT, Consumer and Capital Goods are likely to report solid earnings growth while automobiles, pharmaceuticals, and cement will continue to witness margin pressures leading to subdued earnings

    • Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

      Mitessh Thakkar of mitesshthakkar.com is of the view that one can sell Container Corporation of India with a stop loss of Rs 613 and target of Rs 573 and buy Aurobindo Pharma with a stop loss of Rs 722 and target of Rs 760.

    • Corrective bounce expected anytime, see bearish to rangebound movement on Bank Nifty

      Shabbir Kayyumi of Narnolia Financial Advisors maintained cautious view in this sharply lower trending market till some consolidation starts.

    • Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

      Sudarshan Sukhani of s2analytics.com recommends selling Can Fin Homes with stop loss at Rs 240 and target of Rs 218, Cummins India with stop loss at Rs 665 and target of Rs 635 and Sun TV with stop loss at Rs 625 and target of Rs 575.

    • Buy Sun Pharma: Equity99

      We are expecting strong performance in Q2 also and are recommending a buy in staggered manner for medium to long term, says Sumit Bilgaiyan of Equity99.

    • Buy these 2 midcaps, 1 largecap in a staggered manner for the medium term

      Sumit Bilgaiyan of Equity99 feels valuation looks attractive but sentiment still remains uncertain

    • Sell Nifty index on every rise; 3 stocks which can return up to 15%

      10,870 will act as a strong hurdle whereas the Thursday’s high of 10,755 will act as an immediate resistance. Till the time index is trading below this zone every pullback should be used to short the index, says Aditya Agarwal of Way2Wealth Brokers.

    • Buy Sun Pharmaceutical Industries, target Rs 720: Ashish Chaturmohta

      The stock can be bought at current level and on dips towards Rs 630 with a stop loss below Rs 605 and a target of Rs 720, says Ashish Chaturmohta of Sanctum Wealth Management.

    • Looking for momentum plays? Top 5 stocks which could give 7-13% return in 1-2 months

      On the downside, 200-day moving average which stands at 10,774 levels and 61.8 percent retracement of rise 9,952-11,760 that is around 10,642 will act as next support, says Ashish Chaturmohta of Sanctum Wealth Management.

    • Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

      Mitessh Thakkar of mitesshthakkar.com suggests selling Century Textiles & Industries with a stop loss of Rs 846 and target of Rs 815 and CESC with a stop loss of Rs 883 and target of Rs 830.

    • Friday's crash signals time to 'hide in defensives'; Sun Pharma, Wipro, Dr Reddy’s make good bets

      Our strategy should be to hide ourselves in the defensive sector till the Nifty does not cross the all-time high level of 11,770.

    • Goldman Sachs lists 11 stocks likely to be hit hard by a weak rupee

      These include names such as IOC, BPCL, Hero MotoCorp, Shree Cements, Ambuja Cements, Havells India, HPCL, ACC, Exide Industries, IGL, and Amara Raja Batteries.

    • Global brokerages see limited upside for Indian market. Here are 10 strong buys for 1-2 years

      Goldman Sachs, which was strategically overweight on India since March 2014, has turned slightly cautious towards Indian market in 2018 and lowered its investment view to marketweight from overweight earlier.

    • Asian Paints, JSW Steel among top 10 moneymaking ideas for short term

      In absence of any major cues, Indian market will be dependent on global cues this week as well as the movement of rupee against the US Dollar.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347